We are live on
!
Find out more
AAF
Andra AP-fonden Portfolio holdings
AUM
$8.39B
1-Year Est. Return
21.19%
This Fund
S&P 500
This Quarter
Est. Return
-0.07%
1 Year Est. Return
+21.19%
3 Year Est. Return
+70.53%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.86B
AUM Growth
-$38.5M
(-0.79%)
Cap. Flow
+$72.4M
Cap. Flow
% of AUM
1.49%
Top 10 Holdings %
Top 10 Hldgs %
4.3%
Holding
618
New
24
Increased
289
Reduced
263
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Analog Devices
ADI
|
+$19.3M |
| 2 |
Bath & Body Works
BBWI
|
+$11.5M |
| 3 |
Chubb
CB
|
+$10.8M |
| 4 |
Upstart Holdings
UPST
|
+$10.5M |
| 5 |
AbbVie
ABBV
|
+$9.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$22M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$13.1M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$7.48M |
| 4 |
Reinsurance Group of America
RGA
|
+$7.02M |
| 5 |
XPO
XPO
|
+$6.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.83% |
| 2 | Healthcare | 16.68% |
| 3 | Financials | 13.87% |
| 4 | Consumer Discretionary | 12.11% |
| 5 | Industrials | 11.54% |
Similar funds
NW
QC
VA
MWM
GGHC
FT
DM
GRQ
Andra AP-fonden's Q3 2021 Portfolio in Review
As of Q3 2021, Andra AP-fonden held 618 positions worth $4.86B, down 0.79% from $4.9B the previous quarter. Its ten largest holdings account for 4.3% of the portfolio.
Andra AP-fonden's Q3 2021 filing shows 24 new, 289 increased, 263 reduced and 21 closed positions. Its largest new stake was Analog Devices: 115,031 shares worth $19.3M. The largest sale was Alexion Pharmaceuticals, an estimated $22M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Andra AP-fonden's largest Q3 2021 buy was Analog Devices: 115,031 shares worth $19.3M.
- Andra AP-fonden added most to Otis Worldwide in Q3 2021, an estimated $4.8M increase.
- Andra AP-fonden's biggest Q3 2021 reduction was Jazz Pharmaceuticals, cutting an estimated $5.36M.
- Andra AP-fonden fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $22M.
- Andra AP-fonden's ten largest holdings make up 4.3% of its $4.86B portfolio in Q3 2021.
- Andra AP-fonden opened 24 new positions and closed 21 in Q3 2021.
- Andra AP-fonden's portfolio value fell 0.79% quarter-over-quarter to $4.86B.
Based on Andra AP-fonden's 13F filing for Q3 2021, filed 12 Nov 2021.